SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Asston Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

544445

INE0SJX01015

60.9571459

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.25

141.77

EPS(TTM)

Face Value()

Div & Yield %

3.58

Back

CEAT consolidated net profit declines 96.43% in the June 2026 quarter

Jul 17,2026

Net profit of CEAT declined 96.43% to Rs 4.00 crore in the quarter ended June 2026 as against Rs 112.00 crore during the previous quarter ended June 2025. Sales rose 22.36% to Rs 4318.00 crore in the quarter ended June 2026 as against Rs 3529.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	4318.00	3529.00	22
OPM %	8.45	10.97	-
PBDT	225.00	310.00	-27
PBT	39.00	159.00	-75
NP	4.00	112.00	-96

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)